FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
05/16/2023
Back to search
Official data from USPTO
MAYZENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/16/2023
Trademark type
Word
Nice classes
5
Filing date
09/12/2014
Registration date
04/07/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2021
Last transaction
11/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Novartis Pharma AG, Trademark Department
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe endocrine systemthe respiratory systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteriaautoimmune diseases and disorderskidney diseases and disordersdiabetes; antifungalanti-infectiveantiviral preparations and antibiotics
Publications
History of USPTO decisions and trademark events.
20 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/20/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/20/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
03/20/2023
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/26/2022
C71T
CANCELLED SECTION 71
11/26/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/19/2017
GPNX
NOTIFICATION PROCESSED BY IB
06/26/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/10/2015
FIMP
FINAL DISPOSITION PROCESSED
06/10/2015
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
05/07/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2015
PUBO
PUBLISHED FOR OPPOSITION
01/20/2015
NPUB
NOTICE OF PUBLICATION
12/31/2014
MAFR
APPLICATION FILING RECEIPT MAILED
12/16/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2014
DOCK
ASSIGNED TO EXAMINER
12/11/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2014
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/09/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/04/2014
Continuous trademark protection
Get notified about every new filing that threatens MAYZENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.